M46705
N-Methylformamide
99%
Synonym(s):
N-Formylmethylamine
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
HCONHCH3
CAS Number:
Molecular Weight:
59.07
UNSPSC Code:
12352100
NACRES:
NA.21
PubChem Substance ID:
EC Number:
204-624-6
Beilstein/REAXYS Number:
1098352
MDL number:
Assay:
99%
Form:
liquid
assay
99%
form
liquid
refractive index
n20/D 1.432 (lit.)
bp
198-199 °C (lit.)
mp
−4 °C (lit.)
density
1.011 g/mL at 25 °C (lit.)
SMILES string
[H]C(=O)NC
InChI
1S/C2H5NO/c1-3-2-4/h2H,1H3,(H,3,4)
InChI key
ATHHXGZTWNVVOU-UHFFFAOYSA-N
Legal Information
DuPont product
Still not finding the right product?
Explore all of our products under N-Methylformamide
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Dermal - Repr. 1B
Storage Class
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 1
flash_point_f
231.8 °F - closed cup
flash_point_c
111 °C - closed cup
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
D O Futino et al.
Reproduction in domestic animals = Zuchthygiene, 45(2), 214-220 (2008-11-21)
The aim of the present work was to compare the efficiency of methyl-formamide (MF), dimethyl-formamide (DF) and glycerol (GL) as cryoprotectants in canine semen cryopreservation. For the experiment, pooled semen was submitted to one of the three cryoprotectants, with a
Shih-Min Wang et al.
The Science of the total environment, 388(1-3), 398-404 (2007-09-15)
N,N-dimethylformamide (DMF) could be readily absorbed via skin and inhalation routes. It is difficult, however, to separate the internal dose contribution from skin vapor and inhalation exposure. This study attempts to quantitatively determine the separate skin vapor and inhalation exposure
K Clagett-Carr et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 6(5), 906-918 (1988-05-01)
N-methylformamide (NMF), a polar solvent, is currently being evaluated by the National Cancer Institute (NCI) as an antineoplastic agent because of its activity against colon, mammary, and lung tumor xenografts. Results from preclinical studies suggest that it has radiosensitizing, chemosensitizing